DICP OpenIR
Characterization of Phase I Metabolism of Resibufogenin and Evaluation of the Metabolic Effects on Its Antitumor Activity and Toxicity
Ning, Jing1,3; Yu, Zhen-Long1; Hu, Liang-Hai2; Wang, Chao1,4,5; Huo, Xiao-Kui1; Deng, Sa1; Hou, Jie1; Wu, Jing-Jing3; Ge, Guang-Bo3; Ma, Xiao-Chi1; Yang, Ling3
Source PublicationDRUG METABOLISM AND DISPOSITION
2015-03-01
DOI10.1124/dmd.114.060996
Volume43Issue:3Pages:299-308
Indexed BySCI
SubtypeArticle
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
WOS SubjectPharmacology & Pharmacy
WOS Research AreaPharmacology & Pharmacy
WOS KeywordCARDIAC-GLYCOSIDES ; BUFADIENOLIDES ; PREECLAMPSIA ; MARINOBUFAGENIN ; INHIBITION ; PREVENTS ; CHANSU ; MODEL ; VITRO ; RATS
AbstractResibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has displayed great potential as a chemotherapeutic agent in oncology. However, it is a digoxinlike compound that also exhibits extremely cardiotoxic effects. The present study aimed to characterize the metabolic behaviors of RB in humans as well as to evaluate the metabolic effects on its bioactivity and toxicity. The phase I metabolic profile in human liver microsomes was characterized systemically, and the major metabolite was identified as marinobufagenin (5 beta-hydroxylresibufogenin, 5-HRB) by liquid chromatography-mass spectrometry and nuclear magnetic imaging techniques. Both cytochrome P450 (P450) reaction phenotyping and inhibition assays using P450-selective chemical inhibitors demonstrated that CYP3A4 was mainly involved in RB 5 beta-hydroxylation with much higher selectivity than CYP3A5. Kinetic characterization demonstrated that RB 5 beta-hydroxylation in both human liver microsomes and human recombinant CYP3A4 obeyed biphasic kinetics and displayed similar apparent kinetic parameters. Furthermore, 5-HRB could significantly induce cell growth inhibition and apoptosis in A549 and H1299 by facilitating apoptosome assembly and caspase activation. Meanwhile, 5-HRB displayed very weak cytotoxicity of human embryonic lung fibroblasts, and in mice there was a greater tolerance to acute toxicity. In summary, CYP3A4 dominantly mediated 5b-hydroxylation and was found to be a major metabolic pathway of RB in the human liver, whereas its major metabolite (5-HRB) displayed better druglikeness than its parent compound RB. Our findings lay a solid foundation for RB metabolism studies in humans and encourage further research on the bioactive metabolite of RB.
Language英语
WOS IDWOS:000352002200001
Citation statistics
Cited Times:16[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/146151
Collection中国科学院大连化学物理研究所
Affiliation1.Dalian Med Univ, Coll Pharm, Res Inst Integrated Tradit & Western Med, Dalian 116044, Peoples R China
2.Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China
3.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Peoples R China
4.Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
5.Peking Union Med Coll, Beijing 100021, Peoples R China
Recommended Citation
GB/T 7714
Ning, Jing,Yu, Zhen-Long,Hu, Liang-Hai,et al. Characterization of Phase I Metabolism of Resibufogenin and Evaluation of the Metabolic Effects on Its Antitumor Activity and Toxicity[J]. DRUG METABOLISM AND DISPOSITION,2015,43(3):299-308.
APA Ning, Jing.,Yu, Zhen-Long.,Hu, Liang-Hai.,Wang, Chao.,Huo, Xiao-Kui.,...&Yang, Ling.(2015).Characterization of Phase I Metabolism of Resibufogenin and Evaluation of the Metabolic Effects on Its Antitumor Activity and Toxicity.DRUG METABOLISM AND DISPOSITION,43(3),299-308.
MLA Ning, Jing,et al."Characterization of Phase I Metabolism of Resibufogenin and Evaluation of the Metabolic Effects on Its Antitumor Activity and Toxicity".DRUG METABOLISM AND DISPOSITION 43.3(2015):299-308.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Ning, Jing]'s Articles
[Yu, Zhen-Long]'s Articles
[Hu, Liang-Hai]'s Articles
Baidu academic
Similar articles in Baidu academic
[Ning, Jing]'s Articles
[Yu, Zhen-Long]'s Articles
[Hu, Liang-Hai]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Ning, Jing]'s Articles
[Yu, Zhen-Long]'s Articles
[Hu, Liang-Hai]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.